Jones Financial Companies
MIRM icon

Jones Financial Companies’s Mirum Pharmaceuticals MIRM Stock Holding History

Jones Financial Companies’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$653K Sell
5,277
-1,142
-18% -$115K ﹤0.01% 2095
2026
Q1 		$568K Buy
6,419
+5,474
+579% +$515K ﹤0.01% 1980
2025
Q4 		$74.6K Sell
945
-12
-1% -$861 ﹤0.01% 2342
2025
Q3 		$69.6K Buy
957
+243
+34% +$15.4K ﹤0.01% 2233
2025
Q2 		$36.5K Hold
714
– – ﹤0.01% 2351
2025
Q1 		$32.8K Hold
714
– – ﹤0.01% 2223
2024
Q4 		$29.5K Buy
714
+357
+100% +$14.9K ﹤0.01% 2089
2024
Q3 		$13.9K Buy
+357
New +$14.2K ﹤0.01% 2081

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jones Financial Companies's MIRM Position: Q2 2026 in Review

Jones Financial Companies reduced its Mirum Pharmaceuticals (MIRM) stake by 18% in Q2 2026, selling an estimated $115K and leaving 5,277 shares worth $653K. The position accounts for ﹤0.01% of the portfolio, ranked #2095.

Jones Financial Companies first reported a position in MIRM in Q3 2024 and has held it in 8 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Jones Financial Companies held 5,277 shares of Mirum Pharmaceuticals worth $653K as of Q2 2026.
  • Jones Financial Companies sold 1,142 Mirum Pharmaceuticals shares in Q2 2026, an estimated $115K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #2095 holding.
  • Jones Financial Companies first reported a position in Mirum Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.